Market Place
Sourcing Support
Synbias-Gemini Drives Oncology with Structural Insights
16 Apr 2026 //
PRESS RELEASE
Gemini PharmChem Mannheim Renews GMP Certificate for 6 APIs
08 Apr 2026 //
PRESS RELEASE
Hard and Costly for Many, Already Achieved by Synbias-Gemini
27 Jan 2026 //
PRESS RELEASE
Synbias-Gemini Advances Fludarabine Phosphate for Europe
17 Dec 2025 //
PRESS RELEASE
Four Gemini PharmChem APIs on EU Critical Medicines List
17 Nov 2025 //
PRESS RELEASE
Inside Containment: Safety & Cleanliness in HPAPI Manufacturing
15 Jul 2025 //
PRESS RELEASE
How Synbias-Gemini Becomes the Safety Net of Modern Pharma
16 Jun 2025 //
PRESS RELEASE
Synbias-Gemini Launches Reference Standards Line
16 May 2025 //
PRESS RELEASE
Gemini PharmChem Wins ANVISA GMP Certificate for Idarubicin HCl
09 May 2025 //
PRESS RELEASE
A Level Playing Field for Pharma in Europe
29 Apr 2025 //
PRESS RELEASE
Gemini Launches Pirarubicin in Record Time
07 Apr 2025 //
PRESS RELEASE
API Registrations in China
19 Mar 2025 //
PRESS RELEASE
MP Cademartori Visits Gemini PharmChem in Germany
07 Feb 2025 //
PRESS RELEASE
People Are Used to Production Happening Next Door:GEMINI
07 Jul 2024 //
PRESS RELEASE
Gemini PharmChem Mannheim Faces Challenge, yet Profitability show
18 Jun 2024 //
PRESS RELEASE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.